Aurobindo Pharma's US Subsidiary Receives 11 FDA Observations Following Inspection
Aurobindo Pharma's subsidiary Aurolife Pharma received 11 procedural observations from the US FDA following an 18-day inspection of its North Carolina facility.
© Copyright 2025. All Rights Reserved by MedPath